{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T22:39:15Z","timestamp":1782254355187,"version":"3.54.5"},"reference-count":55,"publisher":"American Society of Hematology","issue":"7","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4,14]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Oral anticoagulants such as warfarin, which function as vitamin K antagonists (VKAs), have long been central to anticoagulation therapy. Warfarin inhibits vitamin K epoxide reductase (VKOR), thereby restricting the availability of reduced vitamin K and impairing \u03b3-carboxylation and activation of vitamin K\u2013dependent clotting factors (VKDCFs). However, warfarin\u2019s clinical use is hindered by a narrow therapeutic index and marked interindividual variability, largely attributable to genetic variation in VKOR, yet it remains the only oral anticoagulant option for clinical conditions such as antiphospholipid antibody syndrome. \u03b3-Glutamyl carboxylase (GGCX), the enzyme that directly modifies VKDCFs, represents an attractive but largely unexplored target for anticoagulation. Using a cell-based high-throughput screen of the Maybridge Hit-Finder compound library (comprising 14\u2009400 drug-like molecules), we identified 21 compounds that inhibited \u03b3-carboxylation of VKDCFs. Subsequent gene-deficient cell-based assays and in vitro enzymatic characterization revealed that compound HF13141-H5 selectively and potently inhibits GGCX activity, with nanomolar half-maximal inhibitory concentrations. Molecular docking with the recently resolved GGCX structure suggested that HF13141-H5 mimics the binding of reduced vitamin K, and site-directed mutagenesis confirmed the critical hydrogen bond with residue N290 within the substrate-binding pocket. Importantly, HF13141-H5 maintained full inhibitory potency against VKOR variants associated with warfarin resistance and demonstrated robust anticoagulant activity in a zebrafish laser-induced endothelial injury model. In summary, we describe the discovery and mechanistic characterization of HF13141-H5 as the first small-molecule GGCX inhibitor. By directly targeting GGCX, HF13141-H5 presents a promising strategy for developing next-generation anticoagulants that could overcome the limitations of warfarin, such as genetic variability and resistance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025018776","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T20:59:08Z","timestamp":1766437148000},"page":"2363-2375","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":2,"title":["Small-molecule inhibition of \u03b3-glutamyl carboxylase reveals a novel anticoagulant strategy"],"prefix":"10.1182","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5006-2790","authenticated-orcid":false,"given":"Guomin","family":"Shen","sequence":"first","affiliation":[{"name":"1Department of Hematology, The Second Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China"},{"name":"2Department of Cell Biology, School of Basic Medical Sciences, Harbin Medical University, Harbin, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6143-8995","authenticated-orcid":false,"given":"Dan","family":"Song","sequence":"additional","affiliation":[{"name":"1Department of Hematology, The Second Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China"},{"name":"2Department of Cell Biology, School of Basic Medical Sciences, Harbin Medical University, Harbin, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8297-0972","authenticated-orcid":false,"given":"Shixin","family":"Li","sequence":"additional","affiliation":[{"name":"3Department of Bioengineering, College of Bioscience and Biotechnology, Yangzhou University, Yangzhou, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8459-2557","authenticated-orcid":false,"given":"Xuejie","family":"Chen","sequence":"additional","affiliation":[{"name":"4Department of Biology, The University of North Carolina at Chapel Hill, Chapel Hill, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9377-5267","authenticated-orcid":false,"given":"Catherine E.","family":"Richter","sequence":"additional","affiliation":[{"name":"5Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5583-2048","authenticated-orcid":false,"given":"Shixia","family":"Dong","sequence":"additional","affiliation":[{"name":"1Department of Hematology, The Second Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China"},{"name":"2Department of Cell Biology, School of Basic Medical Sciences, Harbin Medical University, Harbin, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4572-7111","authenticated-orcid":false,"given":"Yiming","family":"Guo","sequence":"additional","affiliation":[{"name":"1Department of Hematology, The Second Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China"},{"name":"2Department of Cell Biology, School of Basic Medical Sciences, Harbin Medical University, Harbin, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9638-0578","authenticated-orcid":false,"given":"Hongli","family":"Liu","sequence":"additional","affiliation":[{"name":"6School of Interdisciplinary Medicine and Engineering, Harbin Medical University, Harbin, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Shen","sequence":"additional","affiliation":[{"name":"7Henan International Joint Laboratory of Thrombosis and Hemostasis, College of Medicine, Henan University of Science and Technology, Luoyang, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6418-2921","authenticated-orcid":false,"given":"Zhenyu","family":"Hao","sequence":"additional","affiliation":[{"name":"3Department of Bioengineering, College of Bioscience and Biotechnology, Yangzhou University, Yangzhou, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6830-3874","authenticated-orcid":false,"given":"Darrel W.","family":"Stafford","sequence":"additional","affiliation":[{"name":"4Department of Biology, The University of North Carolina at Chapel Hill, Chapel Hill, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2874-4904","authenticated-orcid":false,"given":"Jordan A.","family":"Shavit","sequence":"additional","affiliation":[{"name":"5Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI"},{"name":"8Department of Human Genetics, University of Michigan Medical School, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2517-2231","authenticated-orcid":false,"given":"Qing","family":"Cao","sequence":"additional","affiliation":[{"name":"9State Key Laboratory of Reproductive Medicine and Offspring Health, Nanjing Medical University, Nanjing, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8447-3408","authenticated-orcid":false,"given":"Jian-Ke","family":"Tie","sequence":"additional","affiliation":[{"name":"4Department of Biology, The University of North Carolina at Chapel Hill, Chapel Hill, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"issue":"7","key":"2026041408014730200_bib1","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1073\/pnas.71.7.2730","article-title":"Vitamin K dependent modifications of glutamic acid residues in prothrombin","volume":"71","author":"Stenflo","year":"1974","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"2026041408014730200_bib2","doi-asserted-by":"crossref","first-page":"5820","DOI":"10.1016\/S0021-9258(18)60639-8","article-title":"The identification of matrix Gla protein in cartilage","volume":"263","author":"Hale","year":"1988","journal-title":"J Biol Chem"},{"issue":"21","key":"2026041408014730200_bib3","doi-asserted-by":"crossref","first-page":"11032","DOI":"10.1016\/S0021-9258(19)68551-0","article-title":"Vitamin K-dependent carboxylase. Stoichiometry of carboxylation and vitamin K 2,3-epoxide formation","volume":"256","author":"Larson","year":"1981","journal-title":"J Biol Chem"},{"issue":"6755","key":"2026041408014730200_bib4","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.adk9967","article-title":"Membrane topology inversion of GGCX mediates cytoplasmic carboxylation for antiviral defense","volume":"389","author":"Okazaki","year":"2025","journal-title":"Science"},{"issue":"1","key":"2026041408014730200_bib5","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/s41467-025-55903-0","article-title":"GGCX promotes Eurasian avian-like H1N1 swine influenza virus adaption to interspecies receptor binding","volume":"16","author":"Zou","year":"2025","journal-title":"Nat Commun"},{"issue":"2","key":"2026041408014730200_bib6","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/jth.13217","article-title":"Structural and functional insights into enzymes of the vitamin K cycle","volume":"14","author":"Tie","year":"2016","journal-title":"J Thromb Haemost"},{"issue":"1","key":"2026041408014730200_bib7","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/s41467-023-36446-8","article-title":"A genome-wide CRISPR-Cas9 knockout screen identifies FSP1 as the warfarin-resistant vitamin K reductase","volume":"14","author":"Jin","year":"2023","journal-title":"Nat Commun"},{"issue":"7924","key":"2026041408014730200_bib8","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/s41586-022-05022-3","article-title":"A non-canonical vitamin K cycle is a potent ferroptosis suppressor","volume":"608","author":"Mishima","year":"2022","journal-title":"Nature"},{"issue":"8","key":"2026041408014730200_bib9","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1021\/bi00601a003","article-title":"Mechanism of coumarin action: significance of vitamin K epoxide reductase inhibition","volume":"17","author":"Whitlon","year":"1978","journal-title":"Biochemistry"},{"issue":"13","key":"2026041408014730200_bib10","doi-asserted-by":"crossref","first-page":"3910","DOI":"10.1021\/ja00403a050","article-title":"Model studies for a molecular mechanism of action of oral anticoagulants","volume":"103","author":"Silverman","year":"1981","journal-title":"J Am Chem Soc"},{"issue":"12","key":"2026041408014730200_bib11","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1161\/01.CIR.0000063575.17904.4E","article-title":"American Heart Association\/American College of Cardiology Foundation guide to warfarin therapy","volume":"107","author":"Hirsh","year":"2003","journal-title":"Circulation"},{"issue":"2","key":"2026041408014730200_bib12","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0021-9258(18)51377-6","article-title":"Studies on the hemorrhagic sweet clover disease. V. Identification and synthesis of the hemorrhagic agent","volume":"138","author":"Stahmann","year":"1941","journal-title":"J Biol Chem"},{"issue":"6","key":"2026041408014730200_bib13","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.chest.2019.02.402","article-title":"Extended Anticoagulation for VTE: a systematic review and meta-analysis","volume":"155","author":"Mai","year":"2019","journal-title":"Chest"},{"issue":"6524","key":"2026041408014730200_bib14","doi-asserted-by":"crossref","first-page":"eabc5667","DOI":"10.1126\/science.abc5667","article-title":"Structural basis of antagonizing the vitamin K catalytic cycle for anticoagulation","volume":"371","author":"Liu","year":"2021","journal-title":"Science"},{"issue":"9","key":"2026041408014730200_bib15","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1111\/jth.15800","article-title":"Structural and cellular basis of vitamin K antagonism","volume":"20","author":"Liu","year":"2022","journal-title":"J Thromb Haemost"},{"issue":"18","key":"2026041408014730200_bib16","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1182\/blood-2018-05-846592","article-title":"Evaluation of oral anticoagulants with vitamin K epoxide reductase in its native milieu","volume":"132","author":"Chen","year":"2018","journal-title":"Blood"},{"issue":"9","key":"2026041408014730200_bib17","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/phar.1982","article-title":"Warfarin pharmacogenomics in diverse populations","volume":"37","author":"Kaye","year":"2017","journal-title":"Pharmacotherapy"},{"issue":"19","key":"2026041408014730200_bib18","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1182\/bloodadvances.2020001830","article-title":"American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism","volume":"4","author":"Ortel","year":"2020","journal-title":"Blood Adv"},{"issue":"1","key":"2026041408014730200_bib19","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jacc.2022.10.008","article-title":"Direct oral anticoagulants vs vitamin K antagonists in patients with antiphospholipid syndromes: meta-analysis of randomized trials","volume":"81","author":"Khairani","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"13","key":"2026041408014730200_bib20","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1182\/blood-2018-04-848333","article-title":"Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome","volume":"132","author":"Pengo","year":"2018","journal-title":"Blood"},{"issue":"11","key":"2026041408014730200_bib21","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1016\/j.jtha.2023.06.036","article-title":"Warfarin faring better: vitamin K antagonists beat rivaroxaban and apixaban in the INVICTUS and PROACT Xa trials","volume":"21","author":"Eikelboom","year":"2023","journal-title":"J Thromb Haemost"},{"key":"2026041408014730200_bib22","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/bs.mie.2016.10.015","article-title":"Functional study of the vitamin K cycle enzymes in live cells","volume":"584","author":"Tie","year":"2017","journal-title":"Methods Enzymol"},{"issue":"15","key":"2026041408014730200_bib23","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1182\/blood-2015-10-677633","article-title":"Characterization of vitamin K-dependent carboxylase mutations that cause bleeding and nonbleeding disorders","volume":"127","author":"Tie","year":"2016","journal-title":"Blood"},{"issue":"8","key":"2026041408014730200_bib24","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1111\/jth.12306","article-title":"Evaluation of warfarin resistance using transcription activator-like effector nucleases-mediated vitamin K epoxide reductase knockout HEK293 cells","volume":"11","author":"Tie","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"7","key":"2026041408014730200_bib25","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1182\/blood.2019004234","article-title":"A cell-based high-throughput screen identifies drugs that cause bleeding disorders by off-targeting the vitamin K cycle","volume":"136","author":"Chen","year":"2020","journal-title":"Blood"},{"issue":"8055","key":"2026041408014730200_bib26","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/s41586-024-08484-9","article-title":"Structure and mechanism of vitamin-K-dependent gamma-glutamyl carboxylase","volume":"639","author":"Wang","year":"2025","journal-title":"Nature"},{"issue":"8055","key":"2026041408014730200_bib27","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/s41586-025-08648-1","article-title":"Molecular basis of vitamin-K-driven gamma-carboxylation at the membrane interface","volume":"639","author":"Cao","year":"2025","journal-title":"Nature"},{"issue":"10","key":"2026041408014730200_bib28","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1182\/blood-2010-08-304303","article-title":"Functional study of the vitamin K cycle in mammalian cells","volume":"117","author":"Tie","year":"2011","journal-title":"Blood"},{"issue":"4","key":"2026041408014730200_bib29","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1182\/blood.2020006329","article-title":"\u03b3-Glutamyl carboxylase mutations differentially affect the biological function of vitamin K-dependent proteins","volume":"137","author":"Hao","year":"2021","journal-title":"Blood"},{"issue":"7","key":"2026041408014730200_bib30","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1182\/blood-2017-05-782367","article-title":"Molecular basis of the first reported clinical case of congenital combined deficiency of coagulation factors","volume":"130","author":"Jin","year":"2017","journal-title":"Blood"},{"issue":"1","key":"2026041408014730200_bib31","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nsmb.3333","article-title":"Warfarin traps human vitamin K epoxide reductase in an intermediate state during electron transfer","volume":"24","author":"Shen","year":"2017","journal-title":"Nat Struct Mol Biol"},{"issue":"15","key":"2026041408014730200_bib32","doi-asserted-by":"crossref","first-page":"3893","DOI":"10.1182\/bloodadvances.2023012432","article-title":"Multimodal mechanisms of pathogenic variants in the signal peptide of FIX leading to hemophilia B","volume":"8","author":"Gao","year":"2024","journal-title":"Blood Adv"},{"issue":"51","key":"2026041408014730200_bib33","doi-asserted-by":"crossref","first-page":"19308","DOI":"10.1073\/pnas.0609401103","article-title":"Purified vitamin K epoxide reductase alone is sufficient for conversion of vitamin K epoxide to vitamin K and vitamin K to vitamin KH2","volume":"103","author":"Chu","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"2026041408014730200_bib34","doi-asserted-by":"crossref","first-page":"8735","DOI":"10.1016\/S0021-9258(18)52936-7","article-title":"Characterization of the purified vitamin K-dependent gamma-glutamyl carboxylase","volume":"268","author":"Morris","year":"1993","journal-title":"J Biol Chem"},{"key":"2026041408014730200_bib35","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/bs.mcb.2016.01.003","article-title":"Quantitative methods for studying hemostasis in zebrafish larvae","volume":"134","author":"Rost","year":"2016","journal-title":"Methods Cell Biol"},{"issue":"2","key":"2026041408014730200_bib36","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J Comput Chem"},{"issue":"3","key":"2026041408014730200_bib37","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1359-6446(04)03363-X","article-title":"The case for open-source software in drug discovery","volume":"10","author":"DeLano","year":"2005","journal-title":"Drug Discov Today"},{"issue":"17","key":"2026041408014730200_bib38","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1016\/0006-2952(87)90260-7","article-title":"Warfarin resistance. Vitamin K epoxide reductase of Scottish resistance genes is not irreversibly blocked by warfarin","volume":"36","author":"Thijssen","year":"1987","journal-title":"Biochem Pharmacol"},{"issue":"10","key":"2026041408014730200_bib39","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/s41422-025-01161-0","article-title":"Structural insights into the vitamin K-dependent gamma-carboxylation of osteocalcin","volume":"35","author":"Cao","year":"2025","journal-title":"Cell Res"},{"issue":"9","key":"2026041408014730200_bib40","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1161\/CIRCRESAHA.115.306823","article-title":"Animal models of thrombosis from zebrafish to nonhuman primates: use in the elucidation of new pathologic pathways and the development of antithrombotic drugs","volume":"118","author":"Jagadeeswaran","year":"2016","journal-title":"Circ Res"},{"issue":"2","key":"2026041408014730200_bib41","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s40139-015-0081-3","article-title":"Modeling disorders of blood coagulation in the zebrafish","volume":"3","author":"Kretz","year":"2015","journal-title":"Curr Pathobiol Rep"},{"issue":"5","key":"2026041408014730200_bib42","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/MOH.0000000000000075","article-title":"Zebrafish as a model system for the study of hemostasis and thrombosis","volume":"21","author":"Weyand","year":"2014","journal-title":"Curr Opin Hematol"},{"issue":"1","key":"2026041408014730200_bib43","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1538-7836.2004.00999.x","article-title":"Zebrafish: a genetic model for hemostasis and thrombosis","volume":"3","author":"Jagadeeswaran","year":"2005","journal-title":"J Thromb Haemost"},{"key":"2026041408014730200_bib44","doi-asserted-by":"crossref","first-page":"1175215","DOI":"10.3389\/fcvm.2023.1175215","article-title":"Post-TAVR patients with atrial fibrillation: are NOACs better than VKAs?-A meta-analysis","volume":"10","author":"Wang","year":"2023","journal-title":"Front Cardiovasc Med"},{"issue":"7","key":"2026041408014730200_bib45","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1055\/s-0043-1767728","article-title":"Thrombotic antiphospholipid syndrome and direct oral anticoagulants: unmet needs and review of the literature","volume":"49","author":"Marco-Rico","year":"2023","journal-title":"Semin Thromb Hemost"},{"issue":"4","key":"2026041408014730200_bib46","doi-asserted-by":"crossref","first-page":"ezad340","DOI":"10.1093\/ejcts\/ezad340","article-title":"Optimal management of cardiac surgery patients using direct oral anticoagulants: recommendations for clinical practice","volume":"64","author":"Heuts","year":"2023","journal-title":"Eur J Cardiothorac Surg"},{"issue":"14","key":"2026041408014730200_bib47","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1161\/CIRCULATIONAHA.117.031457","article-title":"Periprocedural outcomes of direct oral anticoagulants versus warfarin in nonvalvular atrial fibrillation","volume":"138","author":"Nazha","year":"2018","journal-title":"Circulation"},{"issue":"7","key":"2026041408014730200_bib48","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2217\/pgs-2017-0207","article-title":"Genotype-guided warfarin therapy: current status","volume":"19","author":"Tavares","year":"2018","journal-title":"Pharmacogenomics"},{"issue":"25","key":"2026041408014730200_bib49","doi-asserted-by":"crossref","first-page":"26694","DOI":"10.1021\/acsomega.5c01116","article-title":"In silico and in vitro studies of potential novel vitamin K epoxide reductase (VKOR) inhibitors suggest an updated structure-activity relationship","volume":"10","author":"Mortel","year":"2025","journal-title":"ACS Omega"},{"issue":"16","key":"2026041408014730200_bib50","doi-asserted-by":"crossref","first-page":"8343","DOI":"10.1080\/07391102.2023.2245071","article-title":"In silico evaluation of pharmacokinetic parameters, delivery, distribution and anticoagulative effects of new 4,7-dihydroxycoumarin derivative","volume":"42","author":"Milanovi\u0107","year":"2024","journal-title":"J Biomol Struct Dyn"},{"key":"2026041408014730200_bib51","doi-asserted-by":"crossref","first-page":"117453","DOI":"10.1016\/j.bmc.2023.117453","article-title":"Design of a structure-activity relationship model of vitamin K epoxide reductase (VKORC1) inhibitors combining chemical synthesis of new compounds, enzymatic assays and molecular modelling","volume":"94","author":"Chatron","year":"2023","journal-title":"Bioorg Med Chem"},{"issue":"3","key":"2026041408014730200_bib52","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/jth.15209","article-title":"A novel vitamin K derived anticoagulant tolerant to genetic variations of vitamin K epoxide reductase","volume":"19","author":"Chen","year":"2021","journal-title":"J Thromb Haemost"},{"issue":"11","key":"2026041408014730200_bib53","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1002\/chem.201806277","article-title":"Cyclooctatetraene: a bioactive cubane paradigm complement","volume":"25","author":"Xing","year":"2019","journal-title":"Chemistry"},{"issue":"2","key":"2026041408014730200_bib54","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1056-8719(02)00166-1","article-title":"The power issue: determination of KB or Ki from IC50. A closer look at the Cheng-Prusoff equation, the Schild plot and related power equations","volume":"46","author":"Cheng","year":"2001","journal-title":"J Pharmacol Toxicol Methods"},{"issue":"23","key":"2026041408014730200_bib55","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem Pharmacol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/7\/2363\/2511851\/blooda_adv-2025-018776-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/7\/2363\/2511851\/blooda_adv-2025-018776-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T12:02:00Z","timestamp":1776168120000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/7\/2363\/557444\/Small-molecule-inhibition-of-glutamyl-carboxylase"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":55,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,4,14]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025018776","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4,14]]},"published":{"date-parts":[[2026,3,31]]}}}